About

Dr. Nianzeng Xing is a pioneering urological surgeon whose work spans minimally invasive oncology, surgical innovation, and workforce development in China. His research focuses on redefining surgical paradigms for prostate, bladder, and kidney cancers—particularly through laparoscopic and robot-assisted techniques. Dr. Xing’s most influential work challenges the necessity of prostate biopsy before radical prostatectomy, proposing that advanced imaging and minimally invasive methods could streamline diagnosis and treatment, a concept that has garnered 16 citations and sparked debate in the field. He has also advanced bladder cancer care by comparing intracorporeal versus extracorporeal ileal conduit reconstruction after laparoscopic cystectomy, contributing 12 citations to the evidence base for optimizing surgical outcomes. Beyond the operating room, Dr. Xing led a landmark census of Chinese urological surgeons (5 citations), providing critical data on training, research capacity, and workforce gaps to inform national policy. His technical innovations include a single-position laparoscopic approach for radical nephrectomy and tumor thrombectomy in renal cell carcinoma, demonstrating his commitment to reducing surgical complexity and patient morbidity. With a career dedicated to merging technical precision with systemic improvement, Dr. Xing stands as a transformative figure in Chinese urology.

Research Focus

Key Achievements

3
H-Index
4
Papers
35
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility of prostatectomy without prostate biopsy in the era of new imaging technology and minimally invasive techniques
16 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Chao-Yang Hospital, Capital Medical University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago